It is suggested that serum ANGPTL3 and urinary ANGPTL3/Cre levels can reflect the degree of urinary protein leakage in patients with nephrotic syndrome and can be used as a marker to assess the severity of nephrotic syndrome in the process of treatment. This evidence concerns the gene ANGPTL3 and nephrotic syndrome.